Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Annals of the Rheumatic Diseases|February 15, 2014
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudyPhilip G Conaghan, Charles Peterfy, Ewa Olech, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexateStanley B Cohen, Edward Keystone, Mark C Genovese, et al.
Seminars in Arthritis and Rheumatism|November 29, 2015
Proceedings from The 8th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) ConferenceOrrin M Troum, Olga L Pimienta, Ewa Olech, et al.
Arthritis and Rheumatism|May 1, 2007
Longitudinal performance evaluation and validation of fixed-flexion radiography of the knee for detection of joint space lossMichael C Nevitt, Charles Peterfy, Ali Guermazi, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort studyBenazir Saleem, Andrew K Brown, Mark Quinn, et al.
Arthritis and Rheumatism|February 1, 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsMark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, et al.
Seminars in Arthritis and Rheumatism|February 19, 2013
Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual ConferencePhilip G Conaghan, Mikkel Ostergaard, Maria Antonietta D'Agostino, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
The Journal of Rheumatology|May 3, 2014
Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trialJoel M Kremer, Charles Peterfy, Anthony S Russell, et al.
Annals of the Rheumatic Diseases|October 21, 2011
Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGEPaul P Tak, William Rigby, Andrea Rubbert-Roth, et al.
Pageof 8